GGrantIndex
← Leaderboards

Radojka Savic

University Of California, San Francisco

$8,230,011
Attributed
$22,216,027
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.4M · FY201525
$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,216,027 · 5

By mechanism

UM1$14,399,999 · 1
R01$6,124,149 · 3
T32$1,691,879 · 1

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Treatment Protocols

Research focus

Treatment ProtocolsTuberculosis TreatmentTuberculosisMultidrug-Resistant TuberculosisTreatment DurationRegimenDoseTuberculosis DrugsMoxifloxacinPharmaceutical PreparationsFutureSamplingSeverity Of IllnessToxic EffectTreatment OutcomePharmacokinetic ModelSafetyDrug Resistance In TuberculosisEnsureDrug KineticsTreatment ResponseSuccessRelapseDrug Resistance

Grant awards (16)

Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium$7,200,000
UM1 · FY2025 · AI · contact PI
Diagnosis of tuberculosis and monitoring of treatment via RNA liquid biopsy$743,651
R01 · FY2025 · AI · contact PI
Clinical Pharmacology, Drug Action and Pharmacogenetics$506,206
T32 · FY2025 · GM · contact PI
Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium$7,199,999
UM1 · FY2024 · AI · contact PI
Clinical Pharmacology, Drug Action and Pharmacogenetics$534,314
T32 · FY2024 · GM · contact PI
Identifying Optimal Treatment Strategies for Tuberculosis Treatment$724,769
R01 · FY2023 · AI · contact PI
Clinical Pharmacology, Drug Action and Pharmacogenetics$651,359
T32 · FY2023 · GM · contact PI
Identifying Optimal Treatment Strategies for Tuberculosis Treatment$742,896
R01 · FY2022 · AI · contact PI
Identifying Optimal Treatment Strategies for Tuberculosis Treatment$749,427
R01 · FY2021 · AI · contact PI
Identifying Optimal Treatment Strategies for Tuberculosis Treatment$776,254
R01 · FY2020 · AI · contact PI
Identifying Optimal Treatment Strategies for Tuberculosis Treatment$786,787
R01 · FY2019 · AI · contact PI
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment$299,535
R01 · FY2019 · HD
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment$311,733
R01 · FY2018 · HD
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment$319,701
R01 · FY2017 · HD
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment$325,815
R01 · FY2016 · HD
Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment$343,581
R01 · FY2015 · HD